BOTANIX PHARMA LTD ORDINARY (BOT) Short Interest

Name: BOTANIX PHARMA LTD ORDINARY (BOT) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

BOTANIX PHARMA LTD ORDINARY (ASX:BOT) had 0.48% of shares reported as short positions as of 16 May 2026, representing 13,067,090 shares. BOTANIX PHARMA LTD ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).

Short interest: 0.48%
Reported positions: 13,067,090
Industry: Pharmaceuticals, Biotechnology & Life Sciences
As of: 16 May 2026

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

BOT

Botanix Pharmaceuticals

Pharmaceuticals, Biotechnology & Life Sciences

Botanix Pharmaceuticals is an Australian clinical dermatology company focused on developing and commercializing innovative treatments for common skin diseases. Their lead product candidate is Sofdra, a potential treatment for primary axillary hyperhidrosis, and they are also developing other products for acne and atopic dermatitis.

Pharmaceuticals

Biotechnology

Life Sciences

ASX

Shorted

short percentage0.48%

reported shorts13.1M

shares on issue2.720B